Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meihua Group, also known as Meihua Holdings, is a global leader in the production of amino acids and bio-based products through large-scale microbial fermentation. The company operates an integrated industrial chain that serves the food, animal nutrition, and pharmaceutical sectors, providing essential ingredients such as monosodium glutamate, lysine, and high-purity pharmaceutical-grade amino acids. Its pharmaceutical portfolio includes products like glutamine, proline, and leucine, which are critical for clinical nutrition, infusion solutions, and the production of pharmaceutical capsules. Leveraging advanced synthetic biology and metabolic engineering, Meihua has established itself as a key supplier in the global biotechnology landscape. The company is headquartered in Tibet and maintains significant manufacturing and R&D facilities across China, including Langfang, Tongliao, and Xinjiang.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meihua Holdings.